Market Indices
Sector Heatmap
MPLT — MapLight Therapeutics, Inc. Common Stock
NasdaqMapLight Therapeutics, Inc. Common Stock
- O
- 9.24
- H
- 9.97
- L
- 8.92
- V
- 494.95K
MPLT — Latest News & Headlines
10 StoriesMapLight Therapeutics, Inc. (MPLT) Stock Price, News, Quote & History - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Stock Price, News, Quote & History Yahoo! Finance Canada
MPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose - Stocktwits
MPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose Stocktwits
Maplight Therapeutics (NASDAQ:MPLT) Stock Falls 5.5% - Here's Why - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Stock Falls 5.5% - Here's Why MarketBeat
MapLight co-founder is joint winner of 2026 Nobel Prize in Medicine - Seeking Alpha
MapLight co-founder is joint winner of 2026 Nobel Prize in Medicine Seeking Alpha
MapLight Therapeutics Celebrates Co-Founder Karl Deisseroth’s 2026 Nobel Prize for Foundational Optogenetics Discoveries - Quiver Quantitative
MapLight Therapeutics Celebrates Co-Founder Karl Deisseroth’s 2026 Nobel Prize for Foundational Optogenetics Discoveries Quiver Quantitative
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Cut to Strong Sell at Wall Street Zen - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Cut to Strong Sell at Wall Street Zen MarketBeat
MPLT Nov 2026 12.500 call (MPLT261120C00012500) Stock Price, News, Quote & History - Yahoo! Finance Canada
MPLT Nov 2026 12.500 call (MPLT261120C00012500) Stock Price, News, Quote & History Yahoo! Finance Canada
MapLight stock falls 46% as InvestingPro Fair Value flagged overvaluation By Investing.com - Investing.com Nigeria
MapLight stock falls 46% as InvestingPro Fair Value flagged overvaluation By Investing.com Investing.com Nigeria
NVTS Stock Falls After-Hours As Navitas’ Wider-Than-Expected Loss Overshadows Revenue Beat — But Retail Bulls Stay Focused On AI Growth - Stocktwits
NVTS Stock Falls After-Hours As Navitas’ Wider-Than-Expected Loss Overshadows Revenue Beat — But Retail Bulls Stay Focused On AI Growth Stocktwits
Maplight Therapeutics (NASDAQ:MPLT) Reaches New 52-Week Low - Here's Why - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Reaches New 52-Week Low - Here's Why MarketBeat